Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
Seminars in Arthritis and Rheumatism
|
April 6, 2015
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
Alvise Berti, Giulio Cavalli, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)
|
November 14, 2020
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients
Giulio Cavalli, Adriana Cariddi, Jacopo Ferrari, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
December 27, 2023
Clinical and functional effects of beta-blocker therapy discontinuation in patients with biventricular heart failure
Massimo Slavich, Gianluca Ricchetti, Barbara Demarchi, et al.
Oncoimmunology
|
July 7, 2017
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti, Giulio Cavalli, Barbara Guglielmi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 3, 2019
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use
Corrado Campochiaro, Giacomo De Luca, Alessandro Tomelleri, et al.
La Radiologia Medica
|
March 22, 2023
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction
Anna Palmisano, Corrado Campochiaro, Davide Vignale, et al.
European Journal of Internal Medicine
|
February 14, 2021
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies
Laura Pasin, Giulio Cavalli, Paolo Navalesi, et al.
Frontiers in Medicine
|
October 14, 2021
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)
Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Rheumatology (Oxford, England)
|
August 28, 2016
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
Seminars in Arthritis and Rheumatism
|
April 6, 2015
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
Alvise Berti, Giulio Cavalli, Corrado Campochiaro, et al.
Rheumatology (Oxford, England)
|
November 14, 2020
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients
Giulio Cavalli, Adriana Cariddi, Jacopo Ferrari, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
December 27, 2023
Clinical and functional effects of beta-blocker therapy discontinuation in patients with biventricular heart failure
Massimo Slavich, Gianluca Ricchetti, Barbara Demarchi, et al.
Oncoimmunology
|
July 7, 2017
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti, Giulio Cavalli, Barbara Guglielmi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 3, 2019
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use
Corrado Campochiaro, Giacomo De Luca, Alessandro Tomelleri, et al.
La Radiologia Medica
|
March 22, 2023
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction
Anna Palmisano, Corrado Campochiaro, Davide Vignale, et al.
European Journal of Internal Medicine
|
February 14, 2021
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies
Laura Pasin, Giulio Cavalli, Paolo Navalesi, et al.
Frontiers in Medicine
|
October 14, 2021
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM)
Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Rheumatology (Oxford, England)
|
August 28, 2016
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Page
of 14